191 related articles for article (PubMed ID: 33609599)
1. N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats.
Witkin JM; Cerne R; Newman AH; Izenwasser S; Smith JL; Tortella FC
Pharmacol Biochem Behav; 2021 Apr; 203():173154. PubMed ID: 33609599
[TBL] [Abstract][Full Text] [Related]
2. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
Lauterbach EC
Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
[TBL] [Abstract][Full Text] [Related]
3. Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice.
Kim HC; Bing G; Jhoo WK; Kim WK; Shin EJ; Im DH; Kang KS; Ko KH
Life Sci; 2003 Jan; 72(7):769-83. PubMed ID: 12479976
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan.
Zapata A; Gasior M; Geter-Douglass B; Tortella FC; Newman AH; Witkin JM
Pharmacol Biochem Behav; 2003 Jan; 74(2):313-23. PubMed ID: 12479950
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
[TBL] [Abstract][Full Text] [Related]
6. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats.
Löscher W; Hönack D
Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092
[TBL] [Abstract][Full Text] [Related]
7. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
Witkin JM; Gasior M; Heifets B; Tortella FC
J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
[TBL] [Abstract][Full Text] [Related]
9. Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
Aram JA; Martin D; Tomczyk M; Zeman S; Millar J; Pohler G; Lodge D
J Pharmacol Exp Ther; 1989 Jan; 248(1):320-8. PubMed ID: 2536430
[TBL] [Abstract][Full Text] [Related]
10. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan.
Nguyen L; Robson MJ; Healy JR; Scandinaro AL; Matsumoto RR
PLoS One; 2014; 9(2):e89985. PubMed ID: 24587167
[TBL] [Abstract][Full Text] [Related]
11. The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan.
Shin EJ; Nah SY; Kim WK; Ko KH; Jhoo WK; Lim YK; Cha JY; Chen CF; Kim HC
Br J Pharmacol; 2005 Apr; 144(7):908-18. PubMed ID: 15723099
[TBL] [Abstract][Full Text] [Related]
12. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices.
Thurgur C; Church J
Br J Pharmacol; 1998 Jul; 124(5):917-29. PubMed ID: 9692777
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [3H]MK-801 binding to N-methyl-D-aspartate receptors in cultured rat cerebellar granule neurons and involvement in glutamate-mediated toxicity.
Berman FW; Murray TF
J Biochem Toxicol; 1996; 11(5):217-26. PubMed ID: 9110243
[TBL] [Abstract][Full Text] [Related]
14. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
15. Dextrorotatory opioids induce stereotyped behavior in Sprague-Dawley and Dark Agouti rats.
Ishmael JE; Franklin PH; Murray TF
Psychopharmacology (Berl); 1998 Nov; 140(2):206-16. PubMed ID: 9860112
[TBL] [Abstract][Full Text] [Related]
16. Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists.
Ginski MJ; Witkin JM
Psychopharmacology (Berl); 1994 May; 114(4):573-82. PubMed ID: 7855218
[TBL] [Abstract][Full Text] [Related]
17. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel.
Franklin PH; Murray TF
Mol Pharmacol; 1992 Jan; 41(1):134-46. PubMed ID: 1370704
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteries.
Kamel IR; Wendling WW; Chen D; Wendling KS; Harakal C; Carlsson C
J Neurosurg Anesthesiol; 2008 Oct; 20(4):241-8. PubMed ID: 18812887
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant effect of dextrometrophan on pentylenetetrazole-induced seizures in mice: Involvement of nitric oxide and N-methyl-d-aspartate receptors.
Mohseni G; Ostadhadi S; Akbarian R; Chamanara M; Norouzi-Javidan A; Dehpour AR
Epilepsy Behav; 2016 Dec; 65():49-55. PubMed ID: 27875784
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat.
Chaplan SR; Malmberg AB; Yaksh TL
J Pharmacol Exp Ther; 1997 Feb; 280(2):829-38. PubMed ID: 9023297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
